ProStrakan’s goal is to build a significant international pharmaceutical company based on a self-sustaining business model. At its most simple, that means bringing products onto the market, either from our R&D portfolio or by licensing, to be sold by our own sales forces.  The revenues from increasing sales of products will, in turn, provide for greater investment in R&D.

Such a business model takes time to achieve by organic growth alone. That's why ProStrakan also seeks appropriate opportunities to grow its commercial operations and to expand its research and development portfolio through corporate and/or product acquisition and through partnering relationships.